Literature DB >> 7864131

Cholestasis is associated with preproenkephalin mRNA expression in the adult rat liver.

N V Bergasa1, S L Sabol, W S Young, D E Kleiner, E A Jones.   

Abstract

Cholestatic liver disease is associated with clinical and experimental findings consistent with increased opioidergic neuromodulation, increased plasma total opioid activity, and elevated plasma enkephalin concentrations. In contrast to the normal adult rat liver, preproenkephalin mRNA was detected by Northern blotting in livers of adult rats with cholestasis due to bile duct resection and not in the sham-resected controls. Preprodynorphin mRNA was not detected in livers of either group, while preproopiomelanocortin mRNA was found in very low levels in both groups. Preproenkephalin mRNA was not expressed in the livers of rats with acute hepatocellular necrosis induced by thioacetamide. Hybridization histochemistry of cholestatic livers demonstrated the presence of preproenkephalin mRNA primarily over cells in the periportal areas, some of which appeared to be proliferating bile ductular cells. Immunohistochemical staining of cholestatic liver indicated the production of at least Met-enkephalin in association with preproenkephalin gene expression. These findings suggest that the liver itself, by synthesizing enkephalins, contributes directly to the abnormalities of the opioid system reported in cholestasis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7864131     DOI: 10.1152/ajpgi.1995.268.2.G346

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  15 in total

Review 1.  Extrahepatic manifestations of cholestatic liver diseases: pathogenesis and therapy.

Authors:  Thomas Pusl; Ulrich Beuers
Journal:  Clin Rev Allergy Immunol       Date:  2005-04       Impact factor: 8.667

Review 2.  Jaundice associated pruritis: a review of pathophysiology and treatment.

Authors:  Ramez Bassari; Jonathan B Koea
Journal:  World J Gastroenterol       Date:  2015-02-07       Impact factor: 5.742

3.  Why do cholestatic patients itch?

Authors:  E A Jones; N V Bergasa
Journal:  Gut       Date:  1996-05       Impact factor: 23.059

4.  Hepatic encephalopathy induces site-specific changes in gene expression of GluN1 subunit of NMDA receptor in rat brain.

Authors:  Shamseddin Ahmadi; Mahsa Poureidi; Jalal Rostamzadeh
Journal:  Metab Brain Dis       Date:  2015-04-22       Impact factor: 3.584

Review 5.  New insights into the pathophysiology and treatment of chronic itch in patients with end-stage renal disease, chronic liver disease, and lymphoma.

Authors:  Hui Wang; Gil Yosipovitch
Journal:  Int J Dermatol       Date:  2010-01       Impact factor: 2.736

Review 6.  Pruritus in chronic liver disease: mechanisms and treatment.

Authors:  Nora V Bergasa
Journal:  Curr Gastroenterol Rep       Date:  2004-02

Review 7.  Cholestasis and endogenous opioids: liver disease and exogenous opioid pharmacokinetics.

Authors:  Mellar Davis
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

Review 8.  Pathogenesis and treatment of pruritus in cholestasis.

Authors:  Andreas E Kremer; Ulrich Beuers; Ronald P J Oude-Elferink; Thomas Pusl
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 9.  Control of cholangiocyte adaptive responses by visceral hormones and neuropeptides.

Authors:  Marco Marzioni; Giammarco Fava; Domenico Alvaro; Gianfranco Alpini; Antonio Benedetti
Journal:  Clin Rev Allergy Immunol       Date:  2009-02       Impact factor: 8.667

10.  Human cholangiocarcinoma development is associated with dysregulation of opioidergic modulation of cholangiocyte growth.

Authors:  M Marzioni; P Invernizzi; C Candelaresi; M Maggioni; S Saccomanno; C Selmi; C Rychlicki; L Agostinelli; B Cassani; M Miozzo; S Pasini; G Fava; G Alpini; A Benedetti
Journal:  Dig Liver Dis       Date:  2008-10-22       Impact factor: 4.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.